glp 1 for perimenopause weight loss GLP-1 Agonists in Perimenopause: Unique Risks and Potential Opportunities GLP-1s and Hormone Therapy: A

These side effects have been primarily seen in with use of these medications over month to a few years with longer term surveillance ongoing

Buffalo Bulletin

Higher IGF-1 promotes: Lipolysis the breakdown of stored fat, particularly visceral fat Lean mass preservation reduced muscle catabolism Improved glucose metabolism better insulin sensitivity at the cellular level Enhanced lipid clearance lower triglycerides, improved lipid profiles Monitoring IGF-1 during tesamorelin therapy is not optional

While probiotic/prebiotic supplementation does not affect thyroid hormone levels, it may modestly reduce TRAb levels in Graves disease patients (Zawadzka et al., 2023

NICE guidance (NG87) recommends baseline cardiovascular assessment before initiating ADHD stimulant treatment, including blood pressure and heart rate measurement, with ongoing monitoring throughout treatment